08:27 AM EDT, 09/09/2024 (MT Newswires) -- Moderna ( MRNA ) said Monday it has received Health Canada's Drug Establishment License for its production site in Laval, Quebec.

With the license, the Laval site will move ahead with the final qualification process to manufacture mRNA vaccines against respiratory viruses, including Covid-19, starting next year, the company said.

Price: 73.25, Change: +0.36, Percent Change: +0.49